Skip to main content

Table 10 Assessment of liver glycogen content in alloxan-induced diabetic rats when treated with EMZSB

From: Screening of Manilkara zapota (L) P. Royen stem bark ethanolic extract for in vitro α-glucosidase inhibition, preliminary antidiabetic effects, and improvement of diabetes and its complications in alloxan-induced diabetes in Wistar rats

Groups Liver glycogen (mg/100 g)
Normal control 18.45 ± 1.06
Diabetic control 11.28 ± 1.15$
Diabetic + Glimepiride 17.58 ± 0.68**
Diabetic + EMZSB 150 13.94 ± 1.36
Diabetic + EMZSB 200 14.34 ± 1.58
Diabetic + EMZSB 250 16. 15 ± 0.84*
  1. Values were presented as mean ± SEM (n = 6); statistics employed was one-way ANOVA followed by Tukey’s multiple comparison test. $p < 0.01 when compared with normal control; *p < 0.05, **p < 0.01 when compared with diabetic control